Kiniksa(US:KNSA) ZACKS·2025-10-14 14:56Core Viewpoint - Kiniksa Pharmaceuticals International, plc (KNSA) has shown a 1.3% increase in share price over the past four weeks, closing at $37.03, with analysts suggesting a potential upside of 29.3% based on a mean price target of $47.88 [1][11]. Price Targets and Analyst Consensus - The average price target for KNSA is derived from eight short-term estimates, ranging from a low of $35.00 to a high of $60.00, with a standard deviation of $7.94, indicating variability in analyst predictions [2]. - The lowest estimate suggests a decline of 5.5%, while the highest indicates a potential upside of 62% [2]. - A low standard deviation signifies a strong agreement among analysts regarding the stock's price movement direction [9]. Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about KNSA's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11]. - Over the past 30 days, one estimate has increased with no negative revisions, leading to a 0.7% rise in the Zacks Consensus Estimate for the current year [12]. Zacks Rank and Investment Potential - KNSA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]. - While the consensus price target may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14].